RN

Transcode Therapeutics IncNASDAQ RNAZ Stock Report

Last reporting period 30 Sep, 2023

Updated 24 Dec, 2024

Last price

Market cap $B

0.007

Micro

Exchange

XNAS - Nasdaq

View Section: Company Analysis

Transcode Rating

RN

RNAZ stock is not rated by Eyestock analysis.

The model does not consider the rating of companies that have no revenue

Discover High-rated Companies


View Section: Valuation